NYSE:LLY • US5324571083
Overall LLY gets a fundamental rating of 7 out of 10. We evaluated LLY against 193 industry peers in the Pharmaceuticals industry. While LLY has a great profitability rating, there are some minor concerns on its financial health. LLY is not overvalued while it is showing excellent growth. This is an interesting combination. LLY also has an excellent dividend rating. With these ratings, LLY could be worth investigating further for dividend and growth investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.89% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.7 | ||
| Fwd PE | 30.08 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 148.28 | ||
| EV/EBITDA | 34.89 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.68% |
1009.52
-13.7 (-1.34%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.68% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.7 | ||
| Fwd PE | 30.08 | ||
| P/S | 16.06 | ||
| P/FCF | 148.28 | ||
| P/OCF | 59.42 | ||
| P/B | 40.11 | ||
| P/tB | 83.36 | ||
| EV/EBITDA | 34.89 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.89% | ||
| ROICexc | 33.3% | ||
| ROICexgc | 41.12% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.06 |
ChartMill assigns a fundamental rating of 7 / 10 to LLY.
ChartMill assigns a valuation rating of 5 / 10 to ELI LILLY & CO (LLY). This can be considered as Fairly Valued.
ELI LILLY & CO (LLY) has a profitability rating of 8 / 10.
The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY) is 41.7 and the Price/Book (PB) ratio is 40.11.
The Earnings per Share (EPS) of ELI LILLY & CO (LLY) is expected to grow by 38.64% in the next year.